Search Results - "Versteijne, E"

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer by Versteijne, E., Vogel, J. A., Besselink, M. G., Busch, O. R. C., Wilmink, J. W., Daams, J. G., van Eijck, C. H. J., Groot Koerkamp, B., Rasch, C. R. N., van Tienhoven, G.

“…Background Studies comparing upfront surgery with neoadjuvant treatment in pancreatic cancer may report only patients who underwent resection and so survival…”
Get full text

Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up" by Huguet et al by Huguet, F, Bouchart, C, Bruynzeel, A M E, Hawkins, M A, Mukherjee, S, Nuyttens, J J, Riou, O, Scorsetti, M, Versteijne, E, Loi, M, Vendrely, V

Get more information

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design by Doppenberg, D, Besselink, M G, van Eijck, C H J, Intven, M P W, Koerkamp, B Groot, Kazemier, G, van Laarhoven, H W M, Meijerink, M, Molenaar, I Q, Nuyttens, J J M E, van Os, R, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Versteijne, E, Wilmink, J W, Lagerwaard, F J, Bruynzeel, A M E

“…Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic)…”
Get full text

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design by Doppenberg, D, Besselink, M G, van Eijck, C H J, Intven, M P W, Groot Koerkamp, B, Kazemier, G, van Laarhoven, H W M, Meijerink, M, Molenaar, I Q, Nuyttens, J J M E, van Os, R, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Versteijne, E, Wilmink, J W, Lagerwaard, F J, Bruynzeel, A M E

Get full text

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort by Doppenberg, D, Lagerwaard, F J, van Dieren, S, Meijerink, M R, van der Vliet, J J, Besselink, M G, van Tienhoven, G, Versteijne, E, Slotman, B J, Wilmink, J W, Kazemier, G, Bruynzeel, A M E

“…The role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is…”
Get full text

Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia by Kok, H P, Korshuize-van Straten, L, Bakker, A, de Kroon-Oldenhof, R, Westerveld, G H, Versteijne, E, Stalpers, L J A, Crezee, J

“…The effectiveness of hyperthermia is strongly dependent on the achieved tumour temperatures. Phased-array systems allow flexible power steering to realise good…”
Get more information

Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern by Versteijne, E., van Laarhoven, H. W. M., van Hooft, J. E., van Os, R. M., Geijsen, E. D., van Berge Henegouwen, M. I., Hulshof, M. C. C. M.

“…SUMMARY A locoregional recurrence after definitive chemoradiation (dCRT) for patients with inoperable or unresectable esophageal cancer occurs in about 50% of…”
Get full text

OC-0282: Considerable intra-breath-hold motion and inter-breathhold position variation of pancreatic tumors by Lens, E, Van der Horst, A, Versteijne, E, Van Tienhoven, G, Bel, A

Get full text

Dosimetric Benefits of Using a Mid-Ventilation or Breath-Hold Approach as an Alternative to Internal Target Volume for Pancreatic Cancer Patients by Lens, E, van der Horst, A, Versteijne, E, van Tienhoven, G, Bel, A

Get full text

EP-1265: Salvage chemoradiation for locoregional recurrences of esophageal cancer after curative treatment by Jeene, P.M, Versteijne, E, Geijsen, E.D, Van Berge Henegouwen, M.I, Bergmann, J.J.G.H.M, Muller, K, Van Laarhoven, H.W.M, Hulshof, M.C.C.M

Get full text

PO-0706: Supraclavicular lymphnode disease is not an independent prognostic factor in esophageal cancer by Jeene, P, Hulshof, M.C.C.M, Versteijne, E, Van Berge Henegouwen, M.I, Bergmann, J.J.G.H.M, Geijsen, E.D, Van Laarhoven, H.W.M

Get full text

Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment by Jeene, P. M., Versteijne, E., van Berge Henegouwen, M. I., Bergmann, J. J. G. H. M., Geijsen, E. D., Muller, K., van Laarhoven, H. W. M., Hulshof, M. C. C. M

“…SUMMARY The aim of this study was to determine the outcome of salvage definitive chemoradiation (dCRT) for a locoregional recurrence after any prior curative…”
Get full text

Clinical Implementation of Single Visit Palliative Adaptive Radiotherapy without Prior CT Simulation by Nelissen, K.J., Versteijne, E., Senan, S., Slotman, B.J., Verbakel, W.F.A.R.

Get full text

PO-1684 Fast delivery of IMRT to metastatic disease without planning CT simulation by Nelissen, K., Versteijne, E., Senan, S., Slotman, B., Verbakel, W.

Get full text

OC-0100 Short course radiation improves pain from pancreatic cancer: A prospective phase II study (NTR5143) by Tello Valverde, C.P., Ebrahimi, G., Wilmink, J.W., Sprangers, M.A., Jacobs, M., Bruynzeel, A., Besselink, M.G., Crezee, H., van Tienhoven, G., Versteijne, E.

Get full text

NRG Oncology International Consensus Atlas on Target Volumes for Dose-Escalated Pancreatic Cancer Radiotherapy by Sanford, N.N., Aguilera, T.A., Bassetti, M.F., Chuong, M.D., Erickson, B.A., Goodman, K.A., Herman, J.M., Hong, T.S., Intven, M.P.W., Kilcoyne, A., Kim, H., Narang, A., Paulson, E.S., Reyngold, M., Tsai, S., Tchelebi, L., Tuli, R., Versteijne, E., Wei, A., Wo, J.Y., Zhang, Y., Hall, W.A.

“…Dose-escalated radiotherapy is increasingly used in the treatment of pancreatic cancer, however approaches to target delineation vary widely. We present the…”
Get full text

Impact of Baseline CA 19-9 on Treatment Effect of Neoadjuvant Chemoradiotherapy in Resectable and Borderline Resectable Pancreatic Cancer in Two RCT's by Doppenberg, D., van Dam, J.L., Han, Y., Busch, O.R., de Hingh, I., Molenaar, I.Q., Versteijne, E., Wilmink, J., Jang, Y.-J., Besselink, M.G., Groot Koerkamp, B.

Get full text

Non-invasive mechanical ventilation is a promising way to improve lung cancer radiotherapy by Veldman-Landegent, J.K., van Kesteren, Z., Parkes, M.J., Stevens, M.F., van den Aardweg, J.G., Dieleman, E.M.T, Versteijne, E., van Tienhoven, G., Bel, A., van Dijk, I.W.E.M.

Get full text

PO-0791 Neoadjuvant treatment potentially improves outcome in resectable pancreatic cancer: metaanalysis by Versteijne, E., Vogel, J.A., Besselink, M.G., Busch, O.R., Wilmink, J.W., Daams, J.G., Van Eijck, C.H., Koerkamp, B. Groot, Rasch, C.R., Van Tienhoven, G.

Get full text

Surgical Complications after Preoperative Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Cancer in a Multicentre, Randomised Controlled Clinical Trial (PREOPANC-1) by van Dongen, J.C., Versteijne, E., Suker, M., Bonsing, B.A., Besselink, M.G., Busch, O.R., van Tienhoven, G., Groot Koerkamp, B., van Eijck, C.H.

Get full text